Evidence map›Paper›PMID 35927486›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2022

Preterm birth among pregnant persons with severe acute respiratory syndrome Coronavirus 2 infection.

Suzanne M Newton, Emily L Reeves, Emily O'Malley Olsen, Kate R Woodworth, Sherry L Farr, Romeo R Galang, Megan R Reynolds, Elizabeth Harvey, Jing Shi, Eirini Nestoridi and 21 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Vaccination, immunity, and the changing impact of COVID-19 on infant health.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 17 institutions in 3 countries.

Suzanne M NewtonCenters for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, GA, USA. snewton@cdc.gov.ORCID 0000-0002-1156-3066
Emily L ReevesCenters for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, GA, USA.
Emily O'Malley OlsenCenters for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, GA, USA.
Kate R WoodworthCenters for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, GA, USA.ORCID 0000-0001-9343-3355
Sherry L FarrCenters for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, GA, USA.
Romeo R GalangCenters for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, GA, USA.ORCID 0000-0001-9837-0699
Megan R ReynoldsCenters for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, GA, USA.ORCID 0000-0001-6362-1646
Elizabeth HarveyTennessee Department of Health, Nashville, TN, USA.
Jing ShiNew Jersey Department of Health, Trenton, NJ, USA.
Eirini NestoridiMassachusetts Department of Public Health, Boston, MA, USA.
Jerusha BartonGeorgia Department of Public Health, Atlanta, GA, USA.
Van P NgoLos Angeles County Department of Public Health, Los Angeles, CA, USA.
Mamie LushNebraska Department of Health and Human Services, Lincoln, NE, USA.
Nicole D LongcoreNew York State Department of Health, Albany, NY, USA.
Paula DzimiraPennsylvania Department of Health, Harrisburg, PA, USA.
Lucille K ImArkansas Department of Health, Little Rock, AR, USA.
Ayomide SokalePhiladelphia Department of Public Health, Philadelphia, PA, USA.
Samantha SiebmanMinnesota Department of Health, Saint Paul, MN, USA.
Camille Delgado LópezPuerto Rico Department of Health, San Juan, Puerto Rico.
Tiffany ChenWashington State Department of Health, Tumwater, WA, USA.ORCID 0000-0002-7897-3203
Evan L MobleyMissouri Department of Health and Senior Services, Jefferson City, MO, USA.
Salma KhuwajaHouston Health Department, Houston, TX, USA.
Paul A RomittiUniversity of Iowa College of Public Health, Iowa City, IA, USA.ORCID 0000-0001-5393-9984
Carolyn FredetteNew Hampshire Department of Health and Human Services, Concord, NH, USA.
Esther M EllisUSVI Department of Health, St Thomas, US.
Kristin SilcoxMaryland Department of Health, Baltimore, MD, USA.
Aron J HallCenters for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, GA, USA.
Eduardo Azziz-BaumgartnerCenters for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, GA, USA.
Suzanne M GilboaCenters for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, GA, USA.
Carrie K Shapiro-MendozaCenters for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA, USA.ORCID 0000-0002-8204-8782
Van T TongCenters for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, GA, USA.
Centers for Disease Control and Prevention · USArkansas Department of Health · USGeorgia Department of Public Health · USHouston Health and Human Services Department · USLos Angeles County Department of Public Health · USMaryland Department of Health · USMassachusetts Department of Public Health · USMinnesota Department of Health · USMissouri Department of Health and Senior Services · USNebraska Department of Health and Human Services · USNew Jersey Department of Health · USNew York State Department of Health · USPennsylvania Department of Health · USPhiladelphia Department of Public Health · USPuerto Rico Department of Health · PRUniversity of Iowa · USWashington State Department of Health · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

objectiveWe examined the relationship between trimester of SARS-CoV-2 infection, illness severity, and risk for preterm birth. STUDY

designWe analyzed data for 6336 pregnant persons with SARS-CoV-2 infection in 2020 in the United States. Risk ratios for preterm birth were calculated for illness severity, trimester of infection, and illness severity stratified by trimester of infection adjusted for age, selected underlying medical conditions, and pregnancy complications.

resultPregnant persons with critical COVID-19 or asymptomatic infection, compared to mild COVID-19, in the second or third trimester were at increased risk of preterm birth. Pregnant persons with moderate-to-severe COVID-19 did not show increased risk of preterm birth in any trimester.

conclusionCritical COVID-19 in the second or third trimester was associated with increased risk of preterm birth. This finding can be used to guide prevention strategies, including vaccination, and inform clinical practices for pregnant persons.

Indexed as

COVID-19Pregnancy Complications, InfectiousPremature BirthFemaleHumansInfant, NewbornPregnancyPregnancy OutcomeSARS-CoV-2United States

Identifiers

PMID35927486
PMCPMC9362668
OpenAlexW4289842890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.